References
- Barentsen R., Groeneveld F. P. M. J., Bareman F. P., Hoes A. W., Dokter H. J., Drogendijk A. C. Women's opinion on withdrawal bleeding with hormone replacement therapy. Eur. J. Obstet. Gynecol Reprod. Biol 1993; 51: 203–7
- Markiewicz L., Gurpide E. in vitro evaluation of estrogenic, estrogen antagonistic and progestogenic effects of a steroidal drug (Org OD-14) and its metabolites on human endometrium. J. Steroid Biochem. 1990; 35: 535–41
- Hammer M., Christau S., Nathorst-Böös J., Rud T., Garre K. A double blind, randomised study comparing the effects of Livial and Kliogest in postmenopausal women with climacteric complaints. Acta Obstet. Gynecol. Scand. 1996; 75: 52–3
- Lindsay P. C., Shaw R. W., Coelingh Bennink H. J., Kicovic P. M. The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl). Fertil. Steril. 1996; 65: 342–8
- Egarter Ch., Hubert J., Leikermoser R., Haid-bauer R., Push H., Fischl F., Putz M. Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints. Maturitas 1996; 23: 55–62
- Rymer J., Chapman M. G., Fogelman I. A study of the effect of tibolone on the vagina in postmenopausal women. Maturitas 1994; 18: 127–33
- Berning B., Kuyk C. V., Kuiper J. W., Coelingh Bennink H. J. T., Kicovic P. M., Fauser B. C. J. M. Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: a two-year randomized, placebo controlled study. Bone 1996; 19: 395–9
- Bjarnason N. H., Bjarnason K., Haarbo J., Rosenquist C., Christiansen C. Tibolone: prevention of bone loss in late postmenopausal women. J. Clin. Endocrinol. Metab. 1996; 81: 2419–22
- Mack T. M., Pike M. C., Henderson B. E., et al. Estrogens and endometrial cancer in a retirement community. N. Engl. J. Med. 1976; 294: 1262–7
- Bergeron C. Evaluation of the effects of HRT on the endometrium – the view from the clinic. 1996; 25, Presented at the 8th International Congress on the Menopause, 3-7 November, 1996, Sydney, Australia, Abstr.
- Coelingh Bennink H. J. T. Livial (tibolone) and the specific endometrial response - the view from recent clinical studies. 1996; 26, Presented at the 8th International Congress on the Menopause, 3–7 November, 1996, Sydney, Australia, Abstr.
- O'Brien M. E. R., Mentes A., Powles T. J. Hormone replacement therapy as treatment of breast cancer - a phase II study of Org OD14 (tibolone). Br. J. Cancer 1996; 73: 1086–8